Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Diphenhydramine

Diphenhydramine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Diphenhydramine

57 trials tracked of Diphenhydramine: 18 in phase 3 or 4 and 2 with published results. The most-cited published study has 1943 citations.

57Trials tracked
18Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 10 Phase 3 8 Phase 2 27 Phase 1 5 Other / NA 7
  1. Phase 3 Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab Completed · 1,943 cited
  2. Phase 3 Metoclopramide for Post Traumatic Headache Completed · 12 cited
  3. Phase 4 Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Completed
  4. Phase 4 Total Joint Arthroplasty and Sleep Completed
  5. Phase 4 A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme Completed
  6. Phase 4 Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness Completed
Show 44 more trials
  1. Phase 4 Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids Completed
  2. Phase 4 Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed Completed
  3. Phase 4 The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine Completed
  4. Phase 4 Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine Completed
  5. Phase 4 Diphenhydramine for Acute Migraine Completed
  6. Phase 4 Lumbar Stenosis Outcomes Research (LUSTOR) Completed
  7. Phase 3 Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria Completed
  8. Phase 3 Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel Completed
  9. Phase 3 A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus Completed
  10. Phase 3 Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers Completed
  11. Phase 3 A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis Completed
  12. Phase 3 A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists Completed
  13. Phase 2 Effects of Inhibiting Early Inflammation in Kidney Transplant Patients Completed
  14. Phase 2 Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood Completed
  15. Phase 2 Simulated Driving Study in Restless Legs Syndrome Completed
  16. Phase 2 Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus Completed
  17. Phase 2 Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients Completed
  18. Phase 2 Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG Completed
  19. Phase 2 Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed
  20. Phase 2 Rituximab and Belimumab for Lupus Nephritis Completed
  21. Phase 2 M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers Completed
  22. Phase 2 A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) Completed
  23. Phase 2 Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults Completed
  24. Phase 2 KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) Completed
  25. Phase 2 Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Completed
  26. Phase 2 Histamine Glutamate Antagonism in Stroke Completed
  27. Phase 2 A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence Completed
  28. Phase 2 Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Completed
  29. Phase 2 Psilocybin-facilitated Treatment for Cocaine Use Completed
  30. Phase 2 BMS 247550 to Treat Kidney Cancer Completed
  31. Phase 2 Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer Completed
  32. Phase 2 E7 TCR T Cells for Human Papillomavirus-Associated Cancers Completed
  33. Phase 2 An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD Completed
  34. Phase 2 Treg Therapy in Subclinical Inflammation in Kidney Transplantation Completed
  35. Phase 2 Metoclopramide for Post-Traumatic Headache. A Pilot Study Completed
  36. Phase 2 Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes Completed
  37. Phase 2 Phase 2 Study of Bexxar in Relapsed/Refractory DLCL Completed
  38. Phase 2 Papillary Serous Carcinoma of the Endometrium Completed
  39. Phase 2 Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction Completed
  40. Phase 1 A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers Completed
  41. Phase 1 CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies Completed
  42. Phase 1 Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies Completed
  43. Phase 1 A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants Completed
  44. Phase 1 Study To Assess The Effect Of Gabapentin, Diphenhydramine And Morphine On Cold Pain In Healthy Male Volunteers Completed

Showing the 50 most-cited and recently-updated of 57 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.